Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

Clinical

RSS  

Articles

  • Biventricular Pacing ECG

    By Michael H. Crawford, MD Synopsis: BiV capture can be accurately detected by observing the R/S ratio in leads V1 and I of the 12-lead ECG.
  • Sudden Death in Patients with Myocardial Infarction and Left Ventricular Dysfunction or Heart Failure

    By John P. DiMarco, MD, PhD Synopsis: The absolute risk for sudden death or cardiac arrest is greatest in the early period after myocardial infarction, and the event rate declines significantly over time. Source: Solomon SD, et al. Sudden Death in Patients With Myocardial Infarction and Left Ventricular Dysfunction, Heart Failure, or Both. N Engl J Med. 2005;352:2581-2588.
  • Amiodarone vs Sotalol for Atrial Fibrillation

    By John P. DiMarco, MD, PhD Professor of Medicine, Division of Cardiology, University of Virginia, Charlottesville Dr. DiMarco is a consultant for Novartis and does research for Medtronic and Guidant. Synopsis: Amiodarone and sotalol have a similar efficacy for converting atrial fibrillation to sinus rhythm, that the drugs do not significantly impair electrical cardioversion and that amiodarone is superior to sotalol which, in turn, is better than placebo, for maintaining sinus rhythm. Source: Singh BN, et al. Amiodarone Versus Sotalol for Atrial Fibrillation. N Engl J Med. 2005;352:1861-1872.
  • Clinical Briefs in Primary Care

    Although persons who work rotating shifts not uncommonly experience transient sleep disturbances, in some individuals who maintain a night-shift jobs, sleep disturbances are persistent and may be accompanied by sleepiness at work.
  • DMPA: Survey offers snapshot of shot use

    Rewind to November 2004: the Food and Drug Administration (FDA) announces the addition of a black box warning to the labeling for the injectable contraceptive depot medroxyprogesterone acetate (DMPA, Depo-Provera, Pfizer, New York City and MedroxyPROGESTERone Injection, Teva Pharmaceuticals USA, North Wales, PA).
  • Intrauterine method sees upswing in use

    More women are choosing long-term birth control through use of intrauterine contraception, say participants in the 2005 Contraceptive Technology Update Contraception Survey.
  • Patch and ring make inroads on birth control pill’s popularity

    As you review the list of contraceptive options available at your family planning facility with your next female patient, which one most likely will receive the nod from her?
  • Washington Watch: FDA fails to rule on EC OTC status . . . again

    On Aug. 26, the U.S. Food and Drug Administration (FDA) announced that it would indefinitely postpone its decision to allow nonprescription status for the emergency contraceptive pill Plan B popularly known as the morning-after pill.
  • How to use OCs? Readers share pill strategies

    As you check the chart of a new patient, you note that she has previously experienced nausea on birth control pills, but cant remember the brand name of her prescribed oral contraceptive (OC). She would like to re-establish pill use. Which OC will you suggest?
  • Pill power: Clinicians speak out on OC choices

    The young woman sitting in front of you is in good health and says she would like to use a birth control pill. Which pill do you prescribe?